Research Article
Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen
Figure 3
Distribution of serum trefoil factor family 3 (TFF3) in differentiated or undifferentiated-type and intestinal- or diffuse-type early gastric cancer (EGC) in the derivation cohort. (a) The serum TFF3 levels of patients with differentiated-type histology and of those with undifferentiated-type EGC did not differ significantly (). (b) Serum TFF3 levels in patients with intestinal-type EGC was significantly higher than that in those with diffuse-type cancer ().
(a) |
(b) |